Order on the coordination of activities relating to and the control of the human immunodeficiency virus in medical interventions connected with the procurement and deposit of semen, 15 June 1988
Annual Review of Population Law 15: 57
1988
ISSN/ISBN: 0364-3417 PMID: 12289613 Document Number: 380053
Section 1 of this Spanish Order lays down that in medical interventions involved in the withdrawal, use, and deposit of semen for human reproduction, appropriate tests, with findings and certification, must be carried out to detect HIV markers. Section 2 specifies that semen obtained from persons who prove to be seropositive must be destroyed, apart from that required for study, analysis, and research. Section 3 requires the same testing, findings, and certification in relation to the recipient woman; in the event of a confirmed positive result, the continuation of the medical intervention must be reconsidered. Section 4 lays down technical and administrative provisions on the tests and their coordination.
Document emailed within 1 workday
Related Documents
Kline, M.W.; Lewis, D.E.; Hollinger, F.B.; Reuben, J.M.; Hanson, L.C.; Kozinetz, C.A.; Dimitrov, D.H.; Rosenblatt, H.M.; Shearer, W.T. 1994: A comparative study of human immunodeficiency virus culture, polymerase chain reaction and anti-human immunodeficiency virus immunoglobulin A antibody detection in the diagnosis during early infancy of vertically acquired human immunodeficiency virus infection Pediatric Infectious Disease Journal 13(2): 90-94Koyanagi, A.; Humphrey, J.H.; Ntozini, R.; Nathoo, K.; Moulton, L.H.; Iliff, P.; Mutasa, K.; Ruff, A.; Ward, B.; Chidawanyika, H.; Hargrove, J.; Mahomva, A.I.; Majo, F.; Malaba, L.C.; Mbizvo, M.T.; Mzengeza, F.; Ndhlovu, M.; Piwoz, E.; Propper, L.; Rambanepasi, P.; Ruff, A.J.; Tavengwa, N.; Zijenah, L.S.; Zunguza, C.D.; Zvandasara, P. 2011: Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy Pediatric Infectious Disease Journal 30(1): 45-51
Krieger, J.N.; Nirapathpongporn, A.; Chaiyaporn, M.; Peterson, G.; Nikolaeva, I.; Akridge, R.; Ross, S.O.; Coombs, R.W. 1998: Vasectomy and human immunodeficiency virus type 1 in semen Journal of Urology 159(3): 820
Ijsselmuiden, C.B.; Padayachee, G.N.; Mashaba, W.; Martiny, O.; van Staden, H.P. 1990: Knowledge, beliefs and practices among black goldminers relating to the transmission of human immunodeficiency virus and other sexually transmitted diseases South African Medical Journal 78(9): 520-523
Dyer, J.R.; Kazembe, P.; Vernazza, P.L.; Gilliam, B.L.; Maida, M.; Zimba, D.; Hoffman, I.F.; Royce, R.A.; Schock, J.L.; Fiscus, S.A.; Cohen, M.S.; Eron, J.J. 1998: High levels of human immunodeficiency virus type 1 in blood and semen of seropositive men in sub-Saharan Africa Journal of Infectious Diseases 177(6): 1742-1746
Berteau, F.; Picaud, A.; Bedjabaga, I. 1993: Seroprevalence of the human immunodeficiency virus (HIV) in pregnant women coming for maternity consultation to the hospital center of Libreville (Gabon) in June 1990 Bulletin de la Societe de Pathologie Exotique 86(2): 130-1; Discussion 131-2
Yue, Q.; Liu, Y.F.; Li, J.; Zang, C.P. 2018: Analysis on late HIV diagnosis among newly reported human immunodeficiency virus/acquired immunodeficiency syndrome cases between 2009 and 2017 in medical institutions Zhonghua Yu Fang Yi Xue Za Zhi 52(12): 1248-1253
Harshbarger, C.L.; O'Donnell, L.N.; Warner, L.; Margolis, A.D.; Richardson, D.B.; Novey, S.R.; Glover, L.C.; Klausner, J.D.; Malotte, C.Kevin.; Rietmeijer, C.A. 2012: Safe in the city: effective prevention interventions for human immunodeficiency virus and sexually transmitted infections American Journal of Preventive Medicine 42(5): 468-472
Sabidó, M.; Lahuerta, M.; Montoliu, A.; Gonzalez, V.; Hernández, G.; Giardina, F.; Monzón, J.é E.; Pedroza, M.I.; Casabona, J. 2011: Human immunodeficiency virus, sexually transmitted infections, and risk behaviors among clients of sex workers in Guatemala: are they a bridge in human immunodeficiency virus transmission? Sexually Transmitted Diseases 38(8): 735-742
Rasheed, S.; Li, Z.; Xu, D.; Kovacs, A. 1996: Presence of cell-free human immunodeficiency virus in cervicovaginal secretions is independent of viral load in the blood of human immunodeficiency virus-infected women American Journal of Obstetrics and Gynecology 175(1): 122-129
Yusim, K.; Peeters, M.; Pybus, O.G.; Bhattacharya, T.; Delaporte, E.; Mulanga, C.; Muldoon, M.; Theiler, J.; Korber, B. 2001: Using human immunodeficiency virus type 1 sequences to infer historical features of the acquired immune deficiency syndrome epidemic and human immunodeficiency virus evolution Philosophical Transactions of the Royal Society of London. Series B Biological Sciences 356(1410): 855-866
Tsurugi, Y.; Eam, K.K.; Eang, M.T.; Uehara, R.; Nakamura, Y.; Murakami, K.; Sugiyama, T.; Yamada, N.; Ishikawa, N. 2011: Evaluation of collaborative tuberculosis and human immunodeficiency virus activities in Phnom Penh, Cambodia The International Journal of Tuberculosis and Lung Disease 15(11): 1535-1539
Shah, V.; Doncel, G.F.; Seyoum, T.; Eaton, K.M.; Zalenskaya, I.; Hagver, R.; Azim, A.; Gross, R. 2005: Sophorolipids, microbial glycolipids with anti-human immunodeficiency virus and sperm-immobilizing activities Antimicrobial Agents and ChemoTherapy 49(10): 4093-4100
Wen, Y.; Guan, J.; Wu, Z.; Li, L.; Rotheram-Borus, M.Jane.; Lin, C.; Detels, R. 2009: Pharmacy workers' sexually transmitted diseases/human immunodeficiency virus knowledge in Fuzhou, China: implications for human immunodeficiency virus testing, treatment, and prevention strategies Sexually Transmitted Diseases 36(4): 221-226
Anonymous 1988: 1988 agent summary statement for human immunodeficiency virus and report on laboratory-acquired infection with human immunodeficiency virus Morbidity and Mortality Weekly Report 37(S-4): 22
Franke, M.F.; Stulac, S.N.; Rugira, I.H.; Rich, M.L.; Bucyibaruta, J.B.; Drobac, P.C.; Iyamungu, G.; Bryant, C.M.; Binagwaho, A.; Farmer, P.E.; Mukherjee, J.S. 2011: High human immunodeficiency virus-free survival of infants born to human immunodeficiency virus-positive mothers in an integrated program to decrease child mortality in rural Rwanda Pediatric Infectious Disease Journal 30(7): 614-616
Monteiro, J.P.; Freimanis-Hance, L.; Faria, L.B.; Mussi-Pinhata, M.M.; Korelitz, J.; Vannucchi, H.él.; Queiroz, W.; Succi, R.C.M.; Hazra, R. 2009: Both human immunodeficiency virus-infected and human immunodeficiency virus-exposed, uninfected children living in Brazil, Argentina, and Mexico have similar rates of low concentrations of retinol, beta-carotene, and vitamin e Nutrition Research 29(10): 716-722
Kidangazhiayathmana, A. 2011: Is Kerala remaining low prevalent in human immunodeficiency virus by accident? a study of risk factors in acquiring human immunodeficiency virus infection in patients attending Anti-retroviral treatment clinic Indian Journal of Dermatology Venereology and Leprology 77(6): 729
Meda, H.A.; Doua, F.; Laveissière, C.; Miezan, T.W.; Gaens, E.; Brattegaard, K.; de Muynck, A.; De Cock, K.M. 1995: Human immunodeficiency virus infection and human African trypanosomiasis: a case-control study in Côte d'Ivoire Transactions of the Royal Society of Tropical Medicine and Hygiene 89(6): 639-643
Scordi-Bello, I.A.; Mosoian, A.; He, C.; Chen, Y.; Cheng, Y.; Jarvis, G.A.; Keller, M.J.; Hogarty, K.; Waller, D.P.; Profy, A.T.; Herold, B.C.; Klotman, M.E. 2005: Candidate sulfonated and sulfated topical microbicides: comparison of anti-human immunodeficiency virus activities and mechanisms of action Antimicrobial Agents and ChemoTherapy 49(9): 3607-3615